SCYX - SCYNEXIS INC

QQQ $ 441.01 $ 0.61 (0.14 %)

DIA $ 394.03 $ 3.92 (1 %)

SPY $ 520.16 $ 2.72 (0.53 %)

TLT $ 90.59 $ 0.55 (0.61 %)

GLD $ 216.93 $ 2.23 (1.04 %)

Previous Close

$ 1.84

Open

$ 1.90

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.85 - $ 1.90

52 Week Range

$ 1.35 - $ 3.87

Volume

116,818

Average Volume

Market Cap

89.36M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

$ 0.88

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-28-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-29-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-29-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-11-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-13-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-08-2017	03-31-2017	10-Q
30	03-13-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-08-2016	06-30-2016	10-Q
33	05-09-2016	03-31-2016	10-Q
34	03-07-2016	12-31-2015	10-K
35	11-13-2015	09-30-2015	10-Q
36	08-19-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-30-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-13-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

SCYNEXIS Q1 2024 GAAP EPS $0.01 Beats $(0....
05/08/2024 22:37:31

SCYNEXIS (NASDAQ:SCYX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.20) by 1...

SCYNEXIS Presented Preclinical Data On Sec...
04/30/2024 20:39:47

In vivo data demonstrated efficacy of SCY-247 in mouse model of invasive candidiasis caused by Candida glabrata SCY-247 showed ...

Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 12:31:45

Cantor Fitzgerald analyst Louise Chen reiterates SCYNEXIS (NASDAQ:SCYX) with a Overweight.

SCYNEXIS Q4 EPS $(0.39) Misses $(0.20) Est...
03/29/2024 03:36:25

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.20) by...

SCYNEXIS Presented Preclinical Data On Sec...
01/29/2024 22:18:02

In vivo data demonstrated response rate for oral SCY-247 similar to current standard of care, intravenous Liposomal Amphoterici...

5-value-stocks-to-watch-in-the-healthcare-sector

5 Value Stocks To Watch In The Healthcare ...
01/29/2024 14:44:11

A Look Into Healthcare Sector Value Stocks
01/08/2024 14:44:03

SCYNEXIS To Present Preclinical Data On Se...
01/05/2024 13:36:59

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-trea...

why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Why Resources Connection Shares Are Tradin...
01/04/2024 12:59:32

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/03/2024 13:05:55

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 21:31:10

SCYNEXIS Entered Into Binding MoU For Amen...
01/02/2024 21:13:34

-SEC Filing Granted for all indications, in all countries other than Greater China and certain other countries already licensed...

SCYNEXIS Q3 EPS $(0.04) Vs $(0.62) Last Ye...
11/13/2023 22:22:49

SCYNEXIS Presents New Preclinical Data On ...
10/24/2023 12:17:09

The analyses were presented by Mahmoud Ghannoum, Ph.D, Professor and Director Center for Medical Mycology, Case Western Reserve...

SCYNEXIS To Present Preclinical Data On Se...
10/16/2023 12:27:06

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-trea...

SCYNEXIS Recalls BREXAFEMME Nationwide Ove...
09/28/2023 06:34:07

gold-moves-lower-transcode-therapeutics-shares-surge

Gold Moves Lower; TransCode Therapeutics S...
09/25/2023 18:43:02

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. Th...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
09/25/2023 17:31:08

why-brainstorm-cell-therapeutics-shares-are-trading-lower-by-33-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Brainstorm Cell Therapeutics Shares Ar...
09/25/2023 17:04:42

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical glib...

Nasdaq Turns Higher; SCYNEXIS Shares Plunge
09/25/2023 16:12:45

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded do...